Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEW-STRAT TB
NCT04951986Phase 3Active, not recruiting
- Sponsor
- University of Cape Town
- Start
- Aug 2021
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rifampicin, levofloxacin, prednisone in Tuberculosis (TB), sponsored by University of Cape Town. Started Aug 2021; status: active, not recruiting.
02
Drugs
rifampicinlevofloxacinprednisone
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT04951986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04951986.